Literature DB >> 16157984

Noninsulinoma pancreatogenous hypoglycemia syndrome: a rare case of adult-onset nesidioblastosis.

Motoyoshi Tsujino1, Toru Sugiyama, Kenji Nishida, Yukari Takada, Kijuro Takanishi, Mitugu Ishizawa, Yukio Hirata.   

Abstract

The most common cause of hyperinsulinemic hypoglycemia in adults is insulinoma. Nesidioblastosis is a rare, but well-recognized disorder of persistent hyperinsulinemic hypoglycemia in infancy, but adult-onset nesidioblastosis associated with hyperinsulinemic hypoglycemia, termed noninsulinoma pancreatogenous hypoglycemic syndrome (NIPHS), has been reported. Here, we describe an extremely rare case of NIPHS in an elderly man. A 78-year-old man was admitted to our hospital due to hypoglycemic coma. During the previous 3 months, he noticed excessive sweating at midafternoon. His low fasting plasma glucose level (27 mg/dl) and high immunoreactive insulin level (11.1 muU/ml) were consistent with the possible presence of insulinoma. Localizing studies including computed tomography of the abdomen and celiac arteriography were negative, but selective arterial calcium infusion (SACI) test suggested the presence of insulinoma in the body and tail of the pancreas. Surgical exploration by palpation and intraoperative ultrasonography failed to detect any mass in the pancreas, and 60% distal pancreatectomy was performed. Postoperatively, his hypoglycemic episodes completely disappeared. Histological examination of the resected pancreas revealed diffuse islet cell hyperplasia consistent with a pathological diagnosis of nesidioblastosis. Thus, our case is a very rare case of NIPHS, or adult-onset nesidioblastosis, in which SACI test was proven to be a useful diagnostic tool for localization of the pancreatic lesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157984     DOI: 10.2169/internalmedicine.44.843

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease.

Authors:  Kimberly A Vanderveen; Clive S Grant; Geoffrey B Thompson; David R Farley; Melanie L Richards; Adrian Vella; Brenda Vollrath; F John Service
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

Review 2.  Hypoglycaemia following upper gastrointestinal surgery: case report and review of the literature.

Authors:  Brandon Bernard; Gregory A Kline; F John Service
Journal:  BMC Gastroenterol       Date:  2010-07-08       Impact factor: 3.067

3.  Hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report.

Authors:  Ran Hong; Dong-Youl Choi; Sung-Chul Lim
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 4.  Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.

Authors:  Ritika R Kapoor; Chela James; Khalid Hussain
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

5.  Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report.

Authors:  Robert Bränström; Erik Berglund; Pontus Curman; Lars Forsberg; Anders Höög; Lars Grimelius; Per-Olof Berggren; Per Mattsson; Per Hellman; Lisa Juntti-Berggren
Journal:  J Med Case Rep       Date:  2010-09-23

6.  Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking Insulinoma.

Authors:  Shunsuke Doi; Takatsugu Yamada; Yoshinori Kito; Shinsaku Obara; Yusuke Fujii; Takao Nishimura; Tatsushi Kato; Hiroyuki Nakayama; Masahiro Tsutsumi; Ryuji Okamura
Journal:  J Endocr Soc       Date:  2021-12-11

7.  A Clinical Case of Insulinoma Presenting with Postprandial Hypoglycemia in a Patient with a History of Gastric Bypass Surgery.

Authors:  Ryosuke Hayashida; Kyoichiro Tsuchiya; Tetsuo Sekine; Takashi Momose; Fuminori Sato; Maya Sakurada; Kenji Nishida; Tatsuya Hayashi; Yasuhiro Morita; Haruka Okada; Noriyoshi Fukushima; Tetsuya Yamada; Motoyoshi Tsujino
Journal:  Intern Med       Date:  2021-10-12       Impact factor: 1.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.